ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.725,58
0,23%
S&P 500
5.307,01
-0,27%
Dow Jones
39.671,04
-0,51%
Euro vs US Dollar
1,08353
0,10%
Bitcoin
69.798,36
1,01%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Celator Pharmaceuticals Inc. (MM) (CPXX)

  7. Celator Pharmaceuticals Inc. (MM) (CPXX) News

CPXX

Celator Pharmaceuticals Inc. (CPXX)

Celator Pharmaceuticals Inc. (MM)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:CPXX
DatumZeitQuelleÜberschriftSymbolFirma
13/02/201821h59Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
15/02/201721h12Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
14/02/201715h02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
30/01/201722h40Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
02/08/201622h02Edgar (US Regulatory)Amended Termination of Registration of a Class of Security Under Section 12(b) (15-12b/a)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
02/08/201612h02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
27/07/201623h50Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
26/07/201612h01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
22/07/201617h30Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
15/07/201622h50Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
13/07/201619h07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
12/07/201623h09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
12/07/201623h05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
12/07/201623h01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
12/07/201622h34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
12/07/201622h25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
12/07/201622h24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
12/07/201622h23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
12/07/201622h23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
12/07/201622h23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
12/07/201622h22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
12/07/201622h20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
12/07/201622h15Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
12/07/201622h12Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
12/07/201622h10Edgar (US Regulatory)Post-effective Amendment to Proposed Securities Act Rule 462(b) Registration Statement (pos462b)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
12/07/201622h06Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
12/07/201622h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
12/07/201615h14Edgar (US Regulatory)(25-NSE)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
12/07/201614h43Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
12/07/201614h41Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:CPXXCelator Pharmaceuticals Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:CPXX

Kürzlich von Ihnen besucht

TG
A4S
Ameriprise Financial
BIT
F17761
Vontobel Financial Produ...
BIT
S29797
Societe Generale Effekten
TSXV
SMY
Search Minerals
LSE
MZO
BIT
P208V0
NLBNPIT208V0 20991231 17...
BIT
DEMR
WisdomTree Emerging Mark...
NASDAQ
CATYW
BIT
P1XYJ4
NLBNPIT1XYJ4 20240621 12...
BIT
P1ZSQ6
NLBNPIT1ZSQ6 20991231 1....
BIT
P20PQ5
NLBNPIT20PQ5 20991231 41...
HITB
KAVAUSDT
Kava BEP2 Token
BIT
F05075
Vontobel
AMEX
LVHI
Franklin International L...
BIT
I09556
IT0005561722 20250915 15...
BIT
S32570
Societe Generale Effekten
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten